AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, R. M.
Right arrow Articles by Siegelman, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, R. M.
Right arrow Articles by Siegelman, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2004; 182:551-557
© American Roentgen Ray Society


Small Renal Cell Carcinomas: Correlation of Size with Tumor Stage, Nuclear Grade, and Histologic Subtype

Raymond M. Hsu1,2, David Y. Chan3 and Stanley S. Siegelman1

1 Russell H. Morgan Department of Radiology, Johns Hopkins Hospital, Baltimore, MD, and Department of Radiology, Johns Hopkins University, 601 N Caroline St., Rm. 4214, Baltimore, MD 21287-0801.
2 Department of Radiology, Stanford University Medical Center, 300 Pasteur Dr., H1307, Stanford, CA 94304-5105.
3 James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD.

OBJECTIVE. Our goal was to correlate the size of renal cell carcinoma with tumor stage, nuclear grade, and histologic subtype in patients treated using partial or radical nephrectomy.

MATERIALS AND METHODS. We retrospectively reviewed 213 consecutive renal cell carcinomas resected at our institution from 1995 through 1999. Three groups of lesions stratified by size (<= 3 cm, > 3–5 cm, > 5 cm) were compared with regard to pathologic findings. Statistical significance was assessed using Fisher's exact test.

RESULTS. Of 50 lesions 3 cm or smaller, 19 (38%) had extension outside the renal capsule (T3 or T4) and 14 (28%) were a high nuclear grade (Fuhrman grade 3 or 4). Lesions 3 cm or smaller and those greater than 3 cm to 5 cm did not differ statistically with regard to T stage or nuclear grade. Lesions larger than 5 cm showed a statistically higher T stage (p < 0.001) and nuclear grade (p = 0.001) than the other smaller lesions. More non–clear cell tumors were found in the two groups of smaller lesions (p = 0.105) but without statistical significance. The majority (58%) of the tumors were asymptomatic and had been detected incidentally on cross-sectional imaging. Lesions larger than 5 cm were significantly more likely to be symptomatic (p < 0.001). Seventy-nine percent of the tumors 3 cm or smaller were incidental, and these lesions did not differ significantly from the symptomatic lesions with regard to stage, grade, or histology.

CONCLUSION. In our study population, renal cell carcinomas up to 3 cm, including asymptomatic lesions, showed a significant incidence of high nuclear grade and tumor extension beyond the renal capsule; these findings support aggressive management of small lesions. Symptomatic status was not an adequate discriminator to guide management. A longitudinal study is necessary to further evaluate the efficacy of current patterns of therapy.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
S. G. Silverman, G. M. Israel, B. R. Herts, and J. P. Richie
Management of the Incidental Renal Mass
Radiology, October 1, 2008; 249(1): 16 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. J. Zagoria, M. A. Traver, D. M. Werle, M. Perini, S. Hayasaka, and P. E. Clark
Oncologic Efficacy of CT-Guided Percutaneous Radiofrequency Ablation of Renal Cell Carcinomas
Am. J. Roentgenol., August 1, 2007; 189(2): 429 - 436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. E. Heilbrun, R. J. Zagoria, A. J. Garvin, M. C. Hall, K. Krehbiel, A. Southwick, and P. E. Clark
CT-Guided Biopsy for the Diagnosis of Renal Tumors Before Treatment with Percutaneous Ablation
Am. J. Roentgenol., June 1, 2007; 188(6): 1500 - 1505.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. Kawamoto, S. Permpongkosol, D. A. Bluemke, E. K. Fishman, and S. B. Solomon
Sequential Changes after Radiofrequency Ablation and Cryoablation of Renal Neoplasms: Role of CT and MR Imaging
RadioGraphics, March 1, 2007; 27(2): 343 - 355.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. G. Silverman, Y. U. Gan, K. J. Mortele, K. Tuncali, and E. S. Cibas
Renal Masses in the Adult Patient: The Role of Percutaneous Biopsy
Radiology, July 1, 2006; 240(1): 6 - 22.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. H. Wang, P. Q. Min, P. J. Wang, W. X. Cheng, X. H. Zhang, Y. Wang, X. H. Zhao, and X. Q. Mao
Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma.
Am. J. Roentgenol., May 1, 2006; 186(5): 1423 - 1430.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Roentgen Ray Society.